Biscayne Neurotherapeutics, Inc. Report issue

For profit Phase 2
Founded: Miami FL United States (2011)
Status: Acquired by Supernus Pharmaceuticals (2018)

Organization Overview

First Clinical Trial
2017
NCT03156439
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Biscayne Neurotherapeutics Australia Pty, Ltd. | Biscayne Neurotherapeutics, Inc.